Literature DB >> 18074865

Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis.

Krzysztof Okoń1, Jerzy Stachura.   

Abstract

In primary glomerulonephritis the degree of interstitial fibrosis governs the renal function. Mast cells participate in renal interstitial fibrosis, but its role remains poorly understood. Some of human mast cells contain chymase and chymase may participate in local angiotensin formation. Material consisted of 35 renal biopsies. The diagnoses included diabetic nephropathy, mesangial glomerulopathy, IgA glomerulopathy and membranous glomerulopathy. Chymase and tryptase-positive cells were stained by immunohistochemistry and counted. Relative interstitial volume (RIV) was measured by point counting method. The density of tryptase-positive cells was 5.26 per 10 high power fields; the density of chymase-positive cells was 2.72. The counts were higher than in controls and highest in diabetic nephropathy. Creatinine serum level was related to density of chymase-positive cells (R = 0.57), density of tryptase-positive cells (R = 0.59) and RIV (R = 0.77). On multiple regression analysis creatinine level was influenced by RIV but also by density of chymase-positive cells. Our findings indicate that both types of mast cells are present in renal interstitium in diabetes and glomerulonephritis, and may influence the renal function. Chymase-positive cells may be more important in this regard.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18074865

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  16 in total

Review 1.  Mast cells and metabolic syndrome.

Authors:  Jie Zhang; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2010-12-23

Review 2.  Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Authors:  Raimund Pichler; Maryam Afkarian; Brad P Dieter; Katherine R Tuttle
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

3.  Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease.

Authors:  J M Zheng; G H Yao; Z Cheng; R Wang; Z H Liu
Journal:  Diabetologia       Date:  2011-12-01       Impact factor: 10.122

Review 4.  Role of the Immune System in Diabetic Kidney Disease.

Authors:  Fionnuala B Hickey; Finian Martin
Journal:  Curr Diab Rep       Date:  2018-03-12       Impact factor: 4.810

5.  Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms.

Authors:  Hongdong Han; Yanrong Chen; Hao Yang; Wei Cheng; Sijing Zhang; Yunting Liu; Qiuhong Liu; Dongfang Liu; Gangyi Yang; Ke Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

Review 6.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

Review 7.  Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?

Authors:  Pitchai Balakumar; Jayarami Reddy; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

8.  Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study.

Authors:  Parvin Rajabi; Azam Bagheri; Mohssen Hani
Journal:  Adv Biomed Res       Date:  2017-04-17

9.  Mast cells in the kidney biopsies of pediatric patients with lupus nephritis.

Authors:  Stéfany Silva Santos; Carolina Marques Ramos; Maria Luiza Gonçalves Dos Reis Monteiro; Juliana Reis Machado; Marlene Antônia Dos Reis; Rosana Rosa Miranda Corrêa; Laura Penna Rocha
Journal:  J Bras Nefrol       Date:  2020-01-31

10.  Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.

Authors:  Michael A Shi; Guo-Ping Shi
Journal:  Front Immunol       Date:  2012-01-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.